Are you Dr. Zimring?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 PO Box
Ste 7301
Atlanta, GA 30322Phone+1 404-712-2174Fax+1 404-727-5764
Summary
- Dr. James Zimring, MD is a board certified pathologist in Atlanta, Georgia. He is currently licensed to practice medicine in Georgia, Virginia, and Washington. He is affiliated with Emory University Hospital and is an Associate Professor at Emory University School of Medicine.
Education & Training
Emory University School of MedicineResidency, Pathology-Anatomic and Clinical, 1999 - 2002- Emory University School of MedicineClass of 1999
Certifications & Licensure
VA State Medical License 2019 - 2026
GA State Medical License 2002 - 2023
WA State Medical License 2014 - 2021- American Board of Pathology Clinical Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- Co-transfection of murine NXPE2 and murine glycophorin A confers reactivity with Ter-119.Gregory R Keele, Ariel M Hay, Nadia K Holness, Arijita Jash, Sarah E Ewald
Haematologica. 2024-11-01 - Primaquine-5,6-Orthoquinone Is Directly Hemolytic to Older G6PD Deficient RBCs in a Humanized Mouse Model.Karolina H Dziewulska-Cronk, Julie A Reisz, Ariel M Hay, Travis Nemkov, Francesca I Cendali
The Journal of Pharmacology and Experimental Therapeutics. 2024-09-18 - 1 citationsHemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.Karolina H Dziewulska, Julie A Reisz, Ariel M Hay, Angelo D'Alessandro, James C Zimring
The Journal of Pharmacology and Experimental Therapeutics. 2023-09-01
Press Mentions
By Steven L Spitalnik Md Clinical Pathology Board Review 1e 1 Harpsc PaperbackJune 27th, 2020
Grant Support
- Platelet Transfusion Induced Transplant Rejection Across Mha Barriers.National Heart, Lung, And Blood Institute2011–2012
- Transfusion Induced BMT RejectionNational Heart, Lung, And Blood Institute2009–2012
- Immunization To Tranfused Rbcs In Regulated By Recipient InflammationNational Heart, Lung, And Blood Institute2011
- Training Grant In Transfusion Medicine (T32)National Heart, Lung, And Blood Institute2009–2011
- Mechanisms Of Immunomodulation By Anti-Rbc AntibodiesNational Heart, Lung, And Blood Institute2008–2009
- Induction Of Immunological Tolerance For Gene TherapyNational Institute Of Allergy And Infectious Diseases2007–2008
- Alloimmunization To Mhas By RBC TransfusionNational Heart, Lung, And Blood Institute2006–2007
- CD8 + Cd75s + Regulatory T Cells In Anti-Tumor ImmunityNational Heart, Lung, And Blood Institute2005–2007
- The Role Of ACH In CD8+ Cytolytic T Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2005
- Selective Depletion Of Alloreactive T Cells In BMTNational Heart, Lung, And Blood Institute2004–2005
- ACH In CD8+ Cytolytic T Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2004
